GO:0140560 xylosyl alpha-1,3-xylosyltransferase activity

Xylosyl alpha-1,3-xylosyltransferase activity (GO:0140560) is a molecular function defined by the catalytic transfer of xylose from UDP-alpha-D-xylose to a protein-linked xylose-glucose disaccharide on EGF-like domains. This activity is a key step in building a specific trisaccharide structure, alpha-D-xylosyl-(1->3)-alpha-D-xylosyl-(1->3)-beta-D-glucosyl, attached to serine residues within EGF-like repeats. The enzyme responsible for this activity belongs to the glycosyltransferase family, which includes enzymes that modify proteins and lipids with sugar chains. Understanding this activity is important because EGF-like domain glycosylation can influence protein folding, stability, and interactions, which are critical for normal development and tissue homeostasis. Researchers study GO:0140560 to dissect the biosynthetic pathways of O-linked glycans on EGF-like domains and to identify the genes encoding the enzymes that carry out these reactions. The activity is conserved in animals and insects, suggesting a fundamental role in metazoan biology. In plants, a related alpha-xylosyltransferase is involved in xyloglucan biosynthesis, highlighting the evolutionary diversity of xylosyltransferase functions. However, GO:0140560 specifically refers to the animal and insect enzyme that modifies EGF-like domains, distinguishing it from plant cell wall xylosyltransferases. Dysregulation of glycosylation pathways, including those involving xylosyltransferases, has been linked to various human diseases, although the precise role of GO:0140560 in disease remains an active area of research. By studying this activity, scientists can gain insights into the molecular mechanisms of extracellular matrix assembly, cell signaling, and potential therapeutic targets. The development of CRISPR-based models and biochemical assays has accelerated the functional characterization of this enzyme activity.

Xylosyl alpha-1,3-xylosyltransferase activity (GO:0140560) is defined as the catalysis of the reaction: UDP-alpha-D-xylose + [protein with EGF-like domain]-3-O-(alpha-D-xylosyl-(1->3)-beta-D-glucosyl)-L-serine = UDP + [protein with EGF-like domain]-3-O-(alpha-D-xylosyl-(1->3)-alpha-D-xylosyl-(1->3)-beta-D-glucosyl)-L-serine. In simpler terms, this enzyme adds a second xylose molecule to an existing xylose-glucose disaccharide on a protein, forming a trisaccharide on EGF-like domains. The enzyme is found in animals and insects and is involved in the biosynthesis of this specific trisaccharide structure on epidermal growth factor-like domains.

Xylosyl alpha-1,3-xylosyltransferase activity is important because it contributes to the structural diversity of EGF-like domain glycosylation, which can affect protein function, stability, and interactions. This activity is part of the complex post-translational modification machinery that regulates extracellular matrix proteins and signaling molecules. Understanding GO:0140560 helps researchers decipher how specific glycan structures are assembled and how they influence biological processes in animals and insects. Moreover, defects in glycosylation pathways are associated with a range of human diseases, making this enzyme activity a potential target for therapeutic intervention.

The following genes and proteins are associated with xylosyl alpha-1,3-xylosyltransferase activity or related glycosylation pathways, based on published literature.

The regulation of xylosyl alpha-1,3-xylosyltransferase activity is not well characterized in the provided literature. However, like other glycosyltransferases, its activity may be regulated by substrate availability, enzyme expression levels, and post-translational modifications. Further research is needed to identify specific regulatory mechanisms.

Defects in glycosylation pathways involving xylosyltransferases have been linked to connective tissue disorders such as Ehlers-Danlos syndrome and cutis laxa. Although direct mutations in the gene encoding GO:0140560 activity have not been definitively established, altered EGF-like domain glycosylation can affect extracellular matrix integrity.

Aberrant glycosylation is a hallmark of cancer, and xylosyltransferase activities can influence tumor cell adhesion, migration, and signaling. The specific role of GO:0140560 in cancer remains to be elucidated, but it may contribute to the glycosylation of EGF-like domain-containing proteins involved in oncogenic pathways.

Proper glycosylation of EGF-like domains is essential for normal development, as these domains are present in key signaling proteins like Notch. Disruption of xylosyl alpha-1,3-xylosyltransferase activity could potentially lead to developmental abnormalities, though direct evidence is currently limited.

In vitro assays using recombinant enzyme and fluorescently labeled acceptor substrates can measure xylosyl alpha-1,3-xylosyltransferase activity. These assays typically monitor the transfer of xylose from UDP-xylose to a synthetic peptide containing the EGF-like domain sequence.

Mass spectrometry-based glycomics and glycoproteomics can identify and quantify the trisaccharide structure on EGF-like domains. This method is useful for confirming the product of the enzyme activity in cells and tissues.

CRISPR-Cas9 can be used to generate knockout, point mutation, or knock-in models to study the function of genes encoding xylosyl alpha-1,3-xylosyltransferase activity. These models allow researchers to assess the consequences of loss or alteration of the activity on protein glycosylation and cellular phenotypes.

Specific antibodies that recognize the xylose-containing trisaccharide can be used in Western blotting, immunofluorescence, or ELISA to detect the modification on proteins. Such tools are valuable for validating enzyme activity in biological samples.

Researchers studying xylosyl alpha-1,3-xylosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in the biosynthesis of the EGF-like domain trisaccharide and how its loss or alteration affects cellular functions. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models, as well as library screening and bioinformatics support.

Xylosyl alpha-1,3-xylosyltransferase activity (GO:0140560) is a specialized glycosyltransferase function that builds a unique trisaccharide on EGF-like domains of proteins in animals and insects. Understanding this activity provides insights into protein glycosylation, extracellular matrix biology, and potential disease mechanisms. With the help of CRISPR-based models and biochemical assays, researchers can continue to unravel the precise roles of this enzyme and its substrates.